First Trust Advisors LP Adaptive Biotechnologies Corp Transaction History

First Trust Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $777,649 - $1.1 Million	125,630 New	125,630 $842,000
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $10.5 Million - $14.6 Million	-326,635 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $5.39 Million - $9.8 Million	-144,731 Reduced 30.7%	326,635 $13.2 Million
Q4 2020 Feb 02, 2021	SELL	$45.01 - $65.47 $3.53 Million - $5.13 Million	-78,356 Reduced 14.25%	471,366 $27.9 Million
Q3 2020 Nov 05, 2020	BUY	$35.79 - $48.81 $17.7 Million - $24.1 Million	493,526 Added 878.22%	549,722 $26.7 Million
Q2 2020 Jul 22, 2020	BUY	$24.95 - $48.38 $1.4 Million - $2.72 Million	56,196 New	56,196 $2.72 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.